|Articles|April 1, 2016
- Applied Clinical Trials-04-01-2016
- Volume 25
- Issue 4
Applied Clinical Trials, April/May 2016 Issue (PDF)
Click the title above to open the Applied Clinical Trials April/May 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Califf: More Informative Clinical Research Key to Drug Developmentabout 10 years ago
EMA Releases New Advice on Human Trials for Cancer Drugsabout 10 years ago
Number of Countries in Phase III Studies Remains Steadyabout 10 years ago
Will EMA Rules Calm the Disclosure Debate?about 10 years ago
Acknowledging Cycle Time Impact from Protocol Amendmentsabout 10 years ago
The Promise of Precision Medicineabout 10 years ago
Value-Based Planning & Drug Development Productivityabout 10 years ago
Overcoming Early Phase Oncology Challengesabout 10 years ago
Imagining the Impossible: Immunity to CancerAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ICON Selects Microsoft as Preferred Technology Partner to Scale Agentic AI Platform Across Clinical Trial Lifecycle
2
ACT Brief: ICON-Microsoft AI Partnership, DCT Site Burden, and AI-Enabled Neuroimmune Discovery
3
ACT Brief: Mixed FSP Strategy, DIA Meeting Trends, and Patient Voice in Oncology
4
HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research
5